Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS

Recruiting Observational Study
Acute Respiratory Distress Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
170 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In this study, 120 patients with Acute Respiratory Distress Syndrome (ARDS) will be included on a two years-period in an intensive care unit (Assistance Publique des Hôpitaux de Marseille, France). Those patients will benefit from a blood test at inclusion in order to measure several coagulation biomarkers, including EV-TF. Subsequently, these patients will be treated according to the usual practi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient 18 years of age or older, * Patient who has given his/her non-opposition to participate in this study, or alternatively, patient for whom a relative has given his/her non-opposition to participate in this study, * Patient admitted to intensive care for less than 24 hou…
Contacts

Giovanni Bousquet, MD

0491964252

giovanni.bousquet@ap-hm.fr

CONTACT

Christophe Guervilly, MD

0491965842

christophe.guervilly@ap-hm.fr

CONTACT